International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.01177

Related search